▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Atlas Arteria in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $5.10.
The current consensus among 1 contributing investment analysts is to hold stock in Atlas Arteria.
Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 13.4% interest in TRIP II, the concessionaire for Dulles Greenway toll road located in northern Virginia, the United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia.